Interrelationship between COVID-19 and diabetes mellitus: a systematic review

Authors

DOI:

https://doi.org/10.33448/rsd-v10i2.12191

Keywords:

COVID-19; Diabetes; Coronavirus; Mechanisms; Infection; Systematic review.

Abstract

Introduction: Individuals with diabetes are at a higher risk of hospitalization and mortality from viral, bacterial and fungal infections. Coronavírus-2019 (COVID-19), caused by severe acute respiratory syndrome coronavírus-2 (SARS-CoV-2), spread rapidly to countries and claimed thousands of lives by December 2020. Notably, in several studies, diabetes is one of the most reported comorbidities in patients with severe COVID-19. Objective: Discuss the influence of diabetes on the prognosis of patients with COVID-19 through a literature review. Methodology: It is a systematic review study. To identify the literature published until December 2020, individual search strategies were applied to the following electronic databases: PubMed, Medline, Lilacs and SciELO. Results: It can be noted that based on the new clinical data obtained from COVID-19 patients, several mechanisms, such as cytokine storm, pulmonary and endothelial dysfunction and hypercoagulation, which can make individuals with diabetes more vulnerable to COVID-19. Epidemiological studies show that poorly controlled diabetes is a risk factor for several infectious diseases. Conclusion: Given the clinical importance of diabetes and the pandemic nature of coronaviruses, understanding how diabetes affects the severity of COVID-19 is critical to the development of public awareness and personalized treatment for individuals affected by the disease.

References

Abu-Farha M., Al-Mulla F., Thanaraj T.A., Kavalakatt S., Ali H., Ghani M.A., & Abubaker J. (2020). Impact of Diabetes in Patients Diagnosed With COVID-19. Front Immunol., 11, 576818.

Alqahtani J. S., Oyelade T., Aldhahir A. M., Alghamdi S. M., Almehmadi M., Alqahtani A. S., Quaderi S., Mandal S., & Hurst J. R. (2020). Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PloS one, 15 (5), e0233147.

Ayres, J.S. (2020). A metabolic handbook for the COVID-19 pandemic. Nat Metab., 2, 572–585.

Bassendine M. F., Bridge S.H., McCaughan G.W., & Gorrell M. D.. (2020). COVID‐19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?. Journal of Diabetes, 12(9), 649– 658.

Bialek S., Boundy E., Bowen V., Chow N., … Sauber-Schatz E. (2020). CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) -. MMWR Morb Mortal Wkly Rep., 69(12),343–346.

Bornstein, S.R., Dalan R. Hopkins D., Mingrone G., & Boehm B.O. (2020). Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol., 16, 297–298.

Chee, Y. J., Ng, S., & Yeoh, E. (2020). Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus. Diabetes research and clinical practice, 164, 108166.

Chen N., Zhou M., Dong X., Qu J., … Zhang L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395 (10223), 507-513.

Cheng H., Wang Y., Wang & G.Q. (2020) Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J Med Virol., 92(7), 726-730.

Chiappetta S., Sharma A.M., Bottino V., Stier C. (2020) COVID-19 and the role of chronic inflammation in patients with obesity. Int J Obes., 44, 1790–1792.

Erener, S. (2020). Diabetes, Infection Risk And Covid-19. Molecular Metabolism., 39, 101044.

Guan W.J., Ni Z.Y., Hu Y., Liang W.H., … Zhong N. (2020). Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med., 382(18), 1708-20.

Guo W., Li M., Dong Y., Zhou H., … Hu D. (2020). Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Ver., e3319.

Gupta, A., Madhavan, M.V., Sehgal, K., Nair N., ... Landry D.W. (2020). Extrapulmonary manifestations of COVID-19. Nature Medicine, 26, 1017–1032.

Gupta, R., Hussain, A. & Misra, A. (2020). Diabetes and COVID-19: evidence, current status and unanswered research questions. Eur J Clin Nutr, 74, 864–870.

Hikmet, F., Méar L., Edvinsson A., Micke P., Uhlén M., & Lindskog C. et al. (2020). The protein expression profile of ACE2 in human tissues. Mol Syst Biol., 16 (7), 1-16.

Huang C., Wang Y., Li X., Ren L., … Cao B. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet., 395 (10223), 497-506.

Iacobellis, G. (2020). COVID-19 and diabetes: Can DPP4 inhibition play a role?. Diabetes Research and Clinical Practice, 163, 108125.

Liao Y.H., Zheng J.Q., Zheng C.M., Lu K.C., & Chao Y.C. Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus. J. Clin. Med., 9 (12), 3962.

Liu M., He P., Liu H.G., Wang X.J., Li F.J., Chen S., Lin J., Chen P., Liu J.H., & Li C.H. (2020). Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi, 43(0), E016.

Ma R.C.W. & Holt R.I.G. (2020). COVID‐19 and diabetes. Diabet. Med., 37 (5), 723– 725.

Maddaloni E., & Buzzetti R. (2020). Covid‐19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev., e33213321.

Mallapaty, S. (2020). Evidence suggests the coronavirus might trigger diabetes. Nature, 583, 16-17.

Monteil, V., Kwon, H., Prado, P., Hagelkruys, A., … Penninger J.M. (2020). Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2 Cell. Célula, 181 (4), 905-913.

Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W. & Northwell M.A.S. (2020). Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. Journal of the American Medical Association, 323 (20), 2052-2059.

Shereen M.A., Khan S., Kazmi A., Bashir N., & Siddique R. (2020) COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses . J Adv Res., 24, 91–8.

Solerte B.S., D’Addio F., Trevisan R., Lovati E., ... Fiorina P. (2020). Sitagliptin Treatment at the Time of Hospitalization Was Associated With

Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study. Diabetes Care., 43 (12), 2999-3006.

Stegenga M.E., Crabben S.N., van der. Blumer R.M., Levi, M. Meijers, J.C. … Tom van der P. (2008). Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia, Blood, 112 (1), 82-89.

Torres-Tamayo M., Caracas-Portillo N.A., Peña-Aparicio B., Juaárez-Rojas J., Medina-Urrutia A. & Martínez-Alvarado M.R. (2020). Infección por coronavirus en pacientes con diabetes. Cardiovasc Metab Sci., 31(3), 235-246.

Varga Z., Flammer A.J., Steiger P., Haberecker M., … Moch, H. (2020). Endothelial cell infection and endotheliitis in COVID-19. Lancet, 395 (10234), 1417-1418.

Wang D., Hu B., Hu C., Zhun F., … Peng Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 323(11), 1061-1069.

Wang W., Lu J., Gu W., Zhang Y., Liu J., & Ning G. (2020). Care for diabetes with COVID-19: advice from China.Journal of Diabetes, 12(5), 417-419.

Wiersinga, W. J., Rhodes A., Cheng A.C., Peacock S.J., & Prescott MD. (2020). Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA, 324(8), 782–793.

Wu Z.H., Tang Y. & Cheng Q. (2020). Diabetes increases the mortality of patients with COVID-19: a meta-analysis. Acta Diabetol, 1-6.

Yang X., Yu Y., Xu J., Shu H., ... Shang Y. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med., 8(5), 475-481.

Downloads

Published

03/02/2021

How to Cite

MARINHO, F. P. .; LOYOLA, I. S. de .; MONTEIRO, I. de O. F. .; CASTRO, T. M.; CARVALHO, M. das G. de S.; GARCIA, J. A. D. .; SILVÉRIO, A. C. P. .; SANTOS, G. B. . Interrelationship between COVID-19 and diabetes mellitus: a systematic review . Research, Society and Development, [S. l.], v. 10, n. 2, p. e4810212191, 2021. DOI: 10.33448/rsd-v10i2.12191. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/12191. Acesso em: 22 nov. 2024.

Issue

Vol. 10 No. 2

Section

Review Article

License

Copyright (c) 2021 Felipe Pereira Marinho; Isabella Santos de Loyola; Igor de Oliveira Freire Monteiro; Tiffani Marioto Castro; Maria das Graças de Souza Carvalho; José Antonio Dias Garcia; Alessandra Cristina Pupin Silvério; Gérsika Bitencourt Santos

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.